Progressive Human Immunodeficiency Virus—Specific Immune Recovery with Prolonged Viral Suppression

作者: Jonathan B. Angel , Karl G. Parato , Ashok Kumar , Stephen Kravcik , Andrew D. Badley

DOI: 10.1086/318547

关键词:

摘要: The degree of immune recovery achievable with anti-human immunodeficiency virus (HIV) therapy remains to be established. effects potent antiretroviral therapy, including ritonavir and saquinavir, on function were studied for a prolonged period in 41 patients. After 96 weeks, 88% patients had plasma HIV RNA levels below the limit quantitation. There continuous increases CD4 lymphocyte counts CD4:CD8 ratios over time. About half developed lymphoproliferative responses p24 antigen, nearly all phytohemagglutinin. This occurred parallel interleukin-12 production expression CD28 CD8 lymphocytes, despite potential antiproliferative protease inhibitors. Transient load temporally associated loss proliferative responses. improved function, HIV-specific immunity many subjects, demonstrates reversibility HIV-induced does not identify recovery.

参考文章(53)
V Viglis, T Kordossis, H Choremi-Papadopoulou, J Kosmidis, A Iniotaki-Theodoraki, P Gargalianos, Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes. ,vol. 7, pp. 245- 253 ,(1994)
Marc Jenkins, S. D. Norton, K. B. Urdahl, P. S. Taylor, CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. Journal of Immunology. ,vol. 147, pp. 2461- 2466 ,(1991)
E John Coligan, Current protocols in immunology Greene Pub. Associates and Wiley-Interscience. ,(1991)
M Battegay, D Moskophidis, A Rahemtulla, H Hengartner, T W Mak, R M Zinkernagel, Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. Journal of Virology. ,vol. 68, pp. 4700- 4704 ,(1994) , 10.1128/JVI.68.7.4700-4704.1994
Nicholas Dainiak, Michael Worthington, Mary Alice Riordan, Sandra Kreczko, Lyle Goldman, 3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. British Journal of Haematology. ,vol. 69, pp. 299- 304 ,(1988) , 10.1111/J.1365-2141.1988.TB02366.X
Barbara N. Phenix, Jonathan B. Angel, Francis Mandy, Stephen Kravcik, Karl Parato, Kelley A. Chambers, Keith Gallicano, Nanci Hawley-Foss, Sharon Cassol, D. William Cameron, Andrew D. Badley, Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Research and Human Retroviruses. ,vol. 16, pp. 559- 567 ,(2000) , 10.1089/088922200308972
Ole Kirk, Terese L. Katzenstein, Jan Gerstoft, Lars Mathiesen, Henrik Nielsen, Court Pedersen, Jens D. Lundgren, Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. AIDS. ,vol. 13, ,(1999) , 10.1097/00002030-199901140-00002
B. Autran, G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debré, J. Leibowitch, Positive Effects of Combined Antiretroviral Therapy on CD4+ T Cell Homeostasis and Function in Advanced HIV Disease Science. ,vol. 277, pp. 112- 116 ,(1997) , 10.1126/SCIENCE.277.5322.112
G. LISIGNOLI, M. C. G. MONACO, A. DEGRASSI, S. TONEGUZZI, E. RICCHI, P. COSTIGLIOLA, A. FACCHINI, In vitro immunotoxicity of +/- 2'-deoxy-3'-thiacytidine, a new anti-HIV agent. Clinical and Experimental Immunology. ,vol. 92, pp. 455- 459 ,(2008) , 10.1111/J.1365-2249.1993.TB03420.X
Daniel Kaufmann, Giuseppe Pantaleo, Philippe Sudre, Amalio Telenti, CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART) The Lancet. ,vol. 351, pp. 723- 724 ,(1998) , 10.1016/S0140-6736(98)24010-4